| Pacific
Bridge Medical - China
Medical Publications |
| |
| China’s Medical Device Market: 2005
|
| |
|
| Internal Publication |
|
| By Ames Gross and Rachel Weintraub |
March 2005
|
 |
|
INTRODUCTION
- ASIA
The expanding
Asian economies and growing medical markets offer considerable opportunities
for US companies. While the medical markets in the US and Europe are well-established
and mature, many US medical companies are experiencing their highest growth
rates (in terms of sales) in the Asian markets. Moreover, most US medical companies
are struggling to keep up with the high costs of R&D, clinical trials and
manufacturing in the US. In order to stay afloat in such a competitive global
market, US medical companies are now, more than ever, also exploring new outsourcing
opportunities in Asia.
Many Asian
nations are experiencing increased Gross Domestic Product (GDP), per capita
income and overall wealth. People in Asia are living longer and demanding better
healthcare products and services. A number of the Asian governments are implementing
more stringent medical device regulations, as they are prepared to spend more
money for higher healthcare standards. Moreover, many of these Asian countries
are placing a greater importance on international regulatory standards in order
to export their medical products globally.
Country |
Medical
Device Market Size |
China |
US
$3.5 billion |
Hong
Kong |
US
$500 million |
Philippines |
US
$75 million |
Indonesia |
US
$150 million |
Japan |
US
$24 billion |
Malaysia |
|
Singapore |
US
$410 million |
Korea |
US
$1.4 billion |
Taiwan |
US
$900 million |
Thailand |
US
$500 million |
OVERVIEW
OF CHINA AND ITS MEDICAL DEVICE MARKET
One of the
fastest growing economies in the world today is China, growing at a rate of
around 9 percent per year. The country’s medical device market is currently
worth approximately $3.5 billion. Following China’s entry into the World
Trade Organization (WTO), the State Food and Drug Administration (SFDA) is making
greater efforts to create a better medical device regulatory environment. In
August 2004, the SFDA implemented new registration requirements, simplifying
the device application and review process. Moreover, exporting to China is becoming
easier for foreign companies, and tariffs on most medical devices have been
reduced to less than four percent as of January 2005. The US is the leading
exporter of medical devices to China, contributing nearly one-third of all China’s
foreign imports.
MEDICAL DEVICE REGULATORY INFORMATION
Overview
Medical devices are regulated in China by the State Food and Drug Administration
(SFDA). The SFDA is the Chinese equivalent of the US Food and Drug Administration
(FDA). The General Administration of Quality, Supervision, Inspection and Quarantine
(AQSIQ) is another Chinese agency that regulates imported medical devices. AQSIQ
conducts mandatory safety registration, certification and inspection for certain
devices. Companies who want to import medical devices into China must register
their device with the SFDA.
Medical
Device Classification
As in the US, medical devices are categorized into three classes, each with
specific regulatory requirements. The classes are as follows:
- Class
I: Low risk devices, regulated by provincial governments
- Class II: Modest risk devices, regulated by provincial governments
- Class III: High risk devices, regulated by the SFDA
Product
Registration Requirements
In order to register a medical device, a total of 12 documents must be collected
and submitted to the SFDA in both Chinese and English, as announced by the SFDA
on March 22, 2005. The required documents are summarized as follows:
1. SFDA
registration form
2. Legal Production Qualification (e.g., US FDA registration)
3. Business license for the Chinese agent registering the product (The agent
must be located in China, have a valid license, and have a letter of commission
from the manufacturer)
4. Marketing approval from government of country of origin (Certificate to Foreign
Government as well as 510(k), pre-market approval (PMA) application for US-made
devices issued by FDA or Free Sale Certificate)
5. Product Standards (ISO, CE, AAMI, etc.); include an authorization letter
to a Chinese agent to translate and reformat the product standard according
to Chinese regulation
6. Operation Manual (Product instructions)
7. Test report issued by SFDA-certified test center (only required for Class
II and III products that have not received ISO9000 certification)
8. Clinical trial report (only required for certain types of devices; manufacturer
may submit clinical trial data that was submitted in the country of origin)
9. Quality guarantee letter (certifying that the product being registered and
sold in China is identical to the product approved in the country of origin)
10. Authorization letter to a Chinese agent, responsible for reporting adverse
events accrued in China (includes an authorization letter from the manufacturer,
and a promise letter from the Chinese agent, the agent’s qualification
document)
11. After-sales authorization (this includes an authorization letter from the
manufacturer, a promise letter from the after-sales agent, and an after-sales
agent qualification document)
12. Self-guarantee declaration (to vouch for truthfulness of submitted documents)
Previously,
all documents executed in the US had to first be authenticated by a Chinese
Embassy or consulate before they were eligible for use in China. As of March
22, 2005, authentication by the Chinese Embassy or consulate is no longer required.
Additionally, copies of government certificates, i.e. Number (4) above, will
be accepted by the SFDA, but should be notarized.
Product
Registration Procedures
On August 9, 2004 the SFDA issued new regulations for the registration of medical
devices in China. These new regulations have (to a certain extent) simplified
the application and dossier review process for medical devices. Additionally,
the Medical Device Clinical Trial Regulation, effective April, 2004, has laid
out more detailed requirements for clinical protocol, clinical hospitals and
clinical reports in China.
Previously,
a company prepared a dossier (with all required documents) and then applied
to the SFDA for a specification validation (for approval of the specifications
of the device to be imported). Once the specification validation was reviewed
and approved, the company was then required to send samples to a testing center.
A company would then file its dossier, with the approved specifications and
the official testing report, to the SFDA. The SFDA would review the technical
documents and judge whether to issue product approval.
The new
regulations have combined the dossier preparation and specification application
into one step. Companies no longer need to apply to the SFDA for specification
validation. Instead, they may use their own specifications as a basis for a
testing agency to provide testing. The company then includes these test results
in its completed dossier and submits it to the SFDA. The SFDA sends this dossier
to the Medical Device Evaluation Center (MDEC) to review the specifications,
dossier, government certificate and clinical report, if needed. The MDEC sends
their conclusion to the SFDA and if everything is acceptable, the SFDA will
issue the product approval license. While these new regulations have somewhat
streamlined the process, they have not significantly altered the timeframe for
medical device registration in China.
However,
there are now several situations that can lengthen the new registration process.
First, if the MDEC requires a supplement dossier, companies must complete the
supplement and re-submit it to the SFDA within 60 working days. Second, since
the specification validation is not required before testing, the testing is
completed based on the company’s specifications. It is possible that the
MDEC may request the company to revise its specifications and re-test, adding
additional time and money to the registration process.
Product
registration is valid for four years. In order to change manufacturing locations
or add a new manufacturing location, a new product registration must be submitted.
To change basic information, such as the manufacturer’s name, product
name, or name of the manufacturing location, etc., an amendment to the product
registration can be submitted. Requests for renewal of product registration
must be made 6 months before the initial registration expires. Along with renewal
forms, a copy of the original registration must be submitted. Product quality
follow-up reports must also be submitted.
Medical
device import licenses approved by the SFDA:
| 2001 |
2002 |
2003 |
2004 |
1st
Qtr 2005 |
| 1,104 |
1,890 |
2,050 |
4,029
|
1,200 |
China
Compulsory Certificate (CCC Mark)
The China Quality Certification Center requires that certain categories of medical
devices obtain a CCC mark to ensure their safety. The CCC mark applies to several
types of medical devices, including medical diagnostic x-ray equipment, haemodialysis
equipment, hollow fiber dialysers, electrocardiographs and implantable cardiac
pacemakers. Manufacturers can apply for the CCC mark directly to an Authorized
Certification Body (ACB) or through a Chinese agent. Products requiring the
CCC mark that are not properly marked may be held at the border by Chinese Customs
and may be subject to other penalties.
Medical
Device Regulation Updates
On July 8, 2004, the SFDA issued new regulations regarding inserts, labeling,
and packaging for medical devices. This was the first regulation of this sort
to exist in China. The new regulation contains detailed requirements for product
inserts, labels and packaging. All medical devices exported to China must include
this information in Chinese. Moreover, the inserts must be reviewed and approved
by the SFDA during product registration. Following approval, the content of
the insert cannot be changed. If any changes must be made, the insert must be
resubmitted to the SFDA for approval again.
The SFDA
released a second draft regulation for new diagnostic device registration procedures
on July 29, 2004. The regulation only applies to diagnostic products categorized
as a medical device, not those categorized as drugs. Registration requirements
for some diagnostic devices are now similar to those for medical devices. The
regulation requires three test batches of the diagnostic device for registration.
However, the draft does not mention whether clinical trials will be required
and this is normally determined on a case by case basis.
DISTRIBUTOR
SEARCH
Overview
Companies that are new to the Asian market and those already engaged in exporting
often sell their products via a network of distributors. This network will be
fundamental to the success of the US medical company exporting to China. Distributors
generally provide services such as warehousing, shipping, sales, marketing,
and service support. When building a distribution network, a foreign company
should keep several things in mind.
Relationships
are key in finding and qualifying distributors—and, ultimately, in successfully
selling a product. The best way for a medical company to find a new distributor
is to investigate distributor groups to which company executives have been introduced
by a trusted personal acquaintance, business colleague, or professional third
party. Signing up distributor groups that a company representative might meet
at a trade show or through cold calling generally does not work. In some Asian
countries including China, if a real relationship with the exporting company
has not been established, the distributor groups can, by Western standards,
lie, cheat, and steal, without doing anything wrong according to the customs
of the home culture. In addition to establishing a solid relationship with a
distributor, the foreign company must keep in mind that face-to-face meetings
are crucial; e-mail correspondence and phone calls alone are not sufficient.
Finding
a Distributor
Finding and qualifying a distributor in China can be a tricky undertaking. Previously,
all medical device distributors in China were state-owned companies, which were
highly bureaucratic (due to the old communist system) and not very market-oriented.
Over the last 7-8 years, private medical device importing companies have begun
to emerge. These groups tend to be more aware of marketing issues and can perform
work faster than state-owned entities. On the other hand, most are relatively
small and not well financed. Moreover, many still lack expertise in the selling
of Western medical device products. In addition, there are not many distributors
that cover the entire country. Thus, a medical company may need to sign up 2-4
private companies to cover China.
When identifying
a distributor, foreign companies should always use “local insight”
to obtain the real background on the distributor. It can be difficult for a
foreign company to determine if the distributor truly knows the medical regulations
and has financial staying power. If possible, a foreign company should contact
other foreign companies that already employ the prospective distributor, or
utilize a consultant who has people on the ground in China. Additionally, it
is crucial to determine the amount of time and effort a Chinese distributor
is willing to spend on your products.
Distributor
Contracts
The contract should account for the differences in each country’s culture
and legal system. Westerners tend to draft lengthy contracts and focus on small
legal details. Conversely, the Chinese conduct business among friends and consider
their relationship to be more valuable than all of the details that are found
in a Western contract. Oftentimes in China, a US company may find itself discussing
points of contention, such as sales targets and product service clauses, even
after the distributor contract is signed.
Distributor
Problems
If distributor problems arise, a foreign manufacturer should not be hasty and
fire a distributor too quickly. Foreign companies who decide to end partnerships
with distributors may find that they have acquired a tarnished reputation in
China and may have trouble securing a new distributor in the future. Therefore,
when problems occur is it best to hold face-to-face meetings and try to come
to a mutual agreement, avoiding legal action whenever possible. Lawyers in China,
as well as most parts of Asia, are generally not held with the same esteem or
used in the same capacity as in many Western countries.
POTENTIAL
FOREIGN BUSINESS STRUCTURES IN CHINA
Overview
Despite the implementation of more-relaxed restrictions on registering and exporting
medical devices, foreign companies still face many difficulties when entering
the Chinese market. Local procurement policies, testing requirements, protection
of intellectual property and restrictions on the types of business activities
in which foreign firms can engage are all potential challenges for foreign medical
device companies.
If a foreign
medical company is interested in setting up a representative office or more
extensive operation in China, there are a number of structures that are possible.
Representative
Office
A Representative Office can be established by foreign company in China for the
purpose of conducting market research, product promotion (but not direct sales),
acting as a liaison, or for other functions that do not involve the operational
activities of the business.
Joint
Venture Structures
There are three main types of Foreign-Invested Enterprises (FIEs) in China:
(1) Equity Joint Ventures (EJVs), Contractual Joint Ventures (CJVs) and Wholly
Owned Foreign Enterprises (WOFEs). FIEs have numerous advantages, such as: (1)
they help foreign medical device companies gain access to China’s domestic
market while still maintaining more control over their activities; (2) they
help foreign companies take advantage of China’s relatively well-educated,
low-cost labor force; (3) they improve access to local resources; and (4) they
generally receive favorable treatment from the Chinese government (tax exemption,
obtaining financing).
In the past,
foreign investment in China was typically done in the form of a joint venture
and most were initially set up as 50/50 joint ventures (or 51/49) between the
foreign and Chinese company. But, restrictions on foreign ownership in China
have eased and there are perceptions that the Chinese side has less to offer
than promised. Therefore, foreign companies who enter joint ventures today typically
control 80-90 percent; the Chinese company holding only 10 or 20 percent. A
foreign company should consider their long-term goals and conduct extensive
research before deciding on a particular type of business structure.
Equity
Joint Venture
An EJV takes the form of a limited liability company with Chinese person legal
status. In this type of structure, parties invest and manage together, sharing
risks and losses in proportion to their contributions. The foreign party’s
contribution must be a minimum of 25 percent and neither party may reduce their
contribution during the venture.
Contractual
Joint Venture
When establishing a CJV, the parties determine the manner of operation, management,
obligations, risk, profit sharing, etc., through an upfront contract. This flexibility
allows companies to establish a CJV quickly in order to take advantage of short-term
business opportunities. In most CJV’s, the foreign party provides most
or all of the funding, technology and key equipment. The Chinese party provides
land, natural resources, facilities and labor. However, the CJV may not have
legal person status or may have limited liability if the enterprise is judged
to be undercapitalized by the State Administration of Industry and Commerce.
Wholly
Owned Foreign Enterprise
WOFE’s are enterprises in which all the funds are provided by foreign
investors. These have become more prevalent in China over the last few years.
A certain percentage of the manufactured products produced by WOFE’s are
required to be sold abroad. Sometimes a separate approval may need to be obtained
to sell locally. Establishing a WOFE offers several advantages over a joint
venture. First, the foreign company has tighter control of their business and
interests including intellectual property protection, since they do not need
to compromise and share information with Chinese partners. Second, the WOFE
can hire its own people and not inherit “dead wood” employees from
a Chinese joint venture company. Nevertheless, WOFEs also have several disadvantages.
For instance, the foreign company has no Chinese partner in which to tap resources
such as an existing distribution network. WOFEs are also sometimes subject to
a higher corporate tax rate than EJVs.
OUTSOURCING
OF MEDICAL DEVICES
Overview
As discussed in the beginning of this report, more US medical companies are
now outsourcing manufacturing to China to reduce their costs. Chinese device
manufacturers have made significant improvements in medical device technology
and product quality. However, identifying the right factory in China can be
a challenge.
Identifying
Manufacturers of Your Product
Presently, one of the best places to begin searching for potential medical device
manufacturers in China is on the Internet. In the past, Chinese manufacturers
often used government-approved trading companies in order to export their products,
so manufacturers typically did not have their own ability to sell their products
overseas. However, as restrictions on import and export regulations have eased,
Chinese manufacturers have begun doing their own direct sales and marketing,
often via the Internet. Now, there is a wealth of information on the Internet
for foreign companies interested in building relationships with manufacturers
in China. Moreover, Chinese manufacturers are becoming more and more comfortable
working and interacting with foreign companies and are accustomed to using English
(albeit sometimes broken English) in many of their business dealings.
A good place
to start your search is on a basic search engine. This will provide you with
an initial list of manufacturers and is a relatively quick process. There are
numerous websites that provide sizeable lists of manufacturers and often include
contact information and a brief description of each manufacturer. However, this
type of search should only be a starting point and should not be considered
as a thorough investigation.
Once several
potential manufacturers have been identified by the Internet search, each manufacturer’s
respective website should be examined. However, it is common for the Chinese
version of the website to be much more detailed than the English version. In
order to establish an accurate idea of the company, both websites should be
viewed by a person fluent in both Chinese and English. Additionally, foreign
companies should keep in mind that all the information on the Internet or an
individual manufacturer’s website may be misleading or inaccurate. It
is vital for companies to take further measures in order to confirm the manufacturer’s
claims.
The
Initial Contact
Once a list a Chinese manufacturers has been compiled, each of these manufacturers
should be contacted directly. Many Chinese manufacturers today will have an
English-speaking employee in their sales office. Nevertheless, it is always
best for a foreign company to have a Chinese speaker available in order to make
the communications go more smoothly. Initially, emails and phone calls should
be used to establish trust and a good business relationship between the foreign
and Chinese companies.
Trust is
crucial to successful business in Asia, so this initial step should not be taken
lightly. These emails and phone calls can also be used to answer initial questions
and confirm the manufacturers’ production capabilities. A foreign company
should ensure that the manufacturer can produce their products to their specifications
and required standards. Moreover, it is not unheard of for a Chinese company
to claim that they are manufacturing a product, when, in fact, they are purchasing
the product from another company and selling it for a higher price. Therefore,
emails and phone calls are not 100 percent sufficient in deciding whether to
pursue business with a company or manufacturer in China.
Determining the Price
After establishing a good business relationship and flow of communication with
a manufacturer, the next step will be to obtain a price quote for your product.
If you have a “standard” product, the price quote should be fairly
straightforward. However, if your product has somewhat unique features or specifications,
or if you are requesting atypical quantities, a general price quote may not
be very useful. In this case, it may be necessary to ask the Chinese manufacturer
for an itemized quote. US companies should also keep in mind that Chinese manufacturers
tend to use metric units and may not be familiar with inches or pounds. It is
also important to ask the manufacturer how long they will honor their price
quote. With a quickly growing economy, prices in China are often increasing,
so a price quote may only be valid for a short period of time. Foreign companies
must also add a number of other expenses into the overall costs of purchasing
medical products from China. International and domestic shipping, customs duties
and possible travel expenses need to also be included in the total cost of sourced
products.
Trading
Company vs. Factory
Even though Chinese manufacturers are increasingly exporting directly overseas,
trading companies are still very common in China. Trading companies act as a
“middleman,” purchasing products from a Chinese manufacturer and
selling the products to a foreign buyer.
Trading
companies offer several advantages. First, these companies tend to have a wide
variety of products available for purchase. A foreign company with numerous
product lines may be able to use one trading company for most of their products,
as opposed to a Chinese manufacturer that could only produce one or two lines.
Second, trading companies can often purchase products for better prices since
they already have well-established relationships (and may make larger purchases)
with manufacturers in China. These prices, in some instances, may even be less
than if a foreign company goes directly to a Chinese manufacturer. Third, it
is usually easier dealing with a trading company since they tend to have more
experience communicating with foreigners (many trading companies have English
speakers) and more experience working with foreign companies. In general, trading
companies offer short-term profits and business relationships with these companies
can be established in less time.
Depending
on a foreign company’s objectives, trading companies are not always the
best way to outsource. If a foreign company is looking to establish a long-term
business relationship in China, direct contact with the Chinese manufacturer
may be more beneficial. The foreign company can develop a long-standing relationship
with a Chinese manufacturer, while also having more control over their product
design and quality. By avoiding trading companies who may cut off your supply
at any time, a direct relationship with a manufacturer will give the buyer a
stronger sense of control and hopefully more leverage on prices as the relationship
and volumes grow.
Due
Diligence
At this point in the manufacturer investigation, most major problems should
have already surfaced. However, there may be smaller problems that could still
cause potential problems for the foreign company. Therefore, prior to visiting
Chinese factories or making a final decision on which factory to visit, due
diligence should be conducted by a local person in China. Local people visiting
Chinese factories can be very helpful. This investigation should include confirming
that the factory has the necessary business licenses and/or registrations, complies
with the required labor laws and working conditions, and that its operations
meet the standards of the foreign company. If the factory uses a great deal
of manual labor, as opposed to machinery, quality control could potentially
be an issue.
Buyers Beware.
A Chinese company could claim to have a very large manufacturing operation with
hundreds of workers when, in fact, it is a trading company with a few people
acting as go-betweens in a small office space. Or, a Chinese manufacturer could
initially offer excellent and speedy service, while actually experiencing financial
trouble and frequent power outages.
Visiting
the Factory
Face-to-face meetings are very important in Asia and crucial to developing a
good working relationship. Once the factory investigation is completed by a
local Chinese and things seem as they were advertised, the foreign company should
arrange to visit the factory in China and begin solidifying the business relationship.
During the visit, it is important to spend time with the key people at the factory,
deciding whether they will be good and honest business partners. These people
also tend to display their business, SFDA and GMP licenses in their office,
so this will be a good opportunity to verify the licenses and ensure they are
valid and up-to-date. If any licenses are missing, this may indicate that the
factory lost their license or never held one at all. It is also a good idea
to ask whether the factory has passed any international requirements (GMP 13845)
or ever filed a 510(k).
It is also
important to get a sense of the factory’s financial background and status.
Many medical device manufacturers have converted from state-owned enterprises
to private companies or joint ventures. However, the details on ownership and
financial contribution can be unclear. If a factory is owned by a single person,
it is best to determine the source of the factory’s initial funding when
possible.
Regulatory
Requirements
Chinese medical device manufacturers exporting to the US are required to meet
specific US FDA regulations. These regulations can cause compliance problems
for Chinese manufacturers, making it difficult to source from certain factories.
Many medical device manufacturers in China have obtained China GMP, CE marks
or ISO certification. However, many of these factories are not able to comply
with the US quality system regulation (QSR), posing a problem for many US companies.
Additionally, any medical device manufacturer that does export to the US must
register with a US Agent and provide this information to the FDA.
Contract
Negotiations
Generally speaking, a contract prepared for a Chinese manufacturer can be similar
to the one normally used with another US company. The contract should include
a fair amount of detail and certain aspects of the agreement should be carefully
spelled-out. In particular, the contract should specify how long the price quote
is valid for and the shipping terms should be well-defined. In trade, the International
Commercial Terms are most common, describing who is responsible for the goods
during each step of the production and delivery process. Chinese tend to use
the term free on board (FOB), specifying that the foreign medical company is
responsible for the products once they reach the dock. It is best to solve sticky
issues and problems via direct face-to-face meetings. However, it is also important
to include a dispute resolution clause in the contract. The clause should define
the law to be applied, such as PRC contract law or Uniform Commercial Code and
establish a procedure for dispute resolution. Arbitration is almost always a
better option than a lawsuit in China.
Quality
Control
The best method for ensuring quality of the products is to implement a quality
assurance system in China. Depending on the shipping terms defined in the contract,
the purchaser may have to pay 100 percent of the cost of the products before
they reach the US. Therefore, it is preferable to inspect the products prior
to shipping. It is possible to hire a local quality control company in China
to conduct an inspection, though this company too should be closely examined
prior to enlisting their service. On the other hand, the majority of Chinese
manufacturers will not object to a visit from their customer’s own quality
control team. This second option involves higher costs, but may be more reliable
and easier to arrange in some instances. It is always a good idea to select
multiple samples from a production run for testing prior to paying 100 percent
of the purchase. If the Chinese manufacturer is aware of these planned visits
or tests, they may be more conscientious of the factory’s quality control
methods from the beginning.
CULTURAL
ISSUES
Business
procedures in China are sometimes very different from business procedures in
the US. Companies planning to do business in China must make an effort to understand
the country’s culture, customs and history in order to establish a sincere
presence in the country.
Western
Approach |
Asian
Approach |
Do
a deal |
Build
relationships |
Maximize
short-term profits |
Establish
long-term foundations |
Be
frank |
Don’t deliver bad news
|
Make
changes quickly |
Move
when ready |
Personal
connections are crucial in China, and essential for conducting successful business.
A foreign company should make a great effort to earn the respect and trust of
a Chinese manufacturing company or distributor before any “real business”
is done. Of course, if possible, it is always best to have a mutual friend serve
as the intermediary when meeting a Chinese company for the first time.
At the time
of the first introduction, business cards should be exchanged. The cards should
be passed with both hands and the names of the cards should be readable by the
receiving party. During the meeting, business cards should be laid out on the
table, as opposed to being placed in a coat pocket or briefcase. Traditionally,
the Chinese give a lot of gifts, so time should be spent choosing an appropriate
one before visiting a Chinese company. If one gift is given, it should be presented
to the head of the Chinese group at a dinner banquet or at the conclusion of
a business meeting. If numerous gifts are given, they should all be of roughly
equal value. When receiving a gift, a humble acceptance and a few words of appreciation
are appropriate.
In Chinese
society, an emphasis is placed on family, humility and courtesy, and the concept
of “face” is very important. When asked to do a favor or go out
of their way, the Chinese will usually avoid saying “no,” since
doing so causes them to lose face. But, if a request cannot be met, the Chinese
may say it is inconvenient, under consideration, or ignore it altogether. Unless
the request is urgent, it is best to respect these subtleties and not press
the issue.
The negotiation
process is almost always longer in China than in the West because the Chinese
enjoy negotiations and want to get the best deal possible. They realize that
foreigners oftentimes like to go home with a deal done, so the Chinese may stretch
out the time to do the deal. In order to carry out successful negotiations,
US companies should keep the following differences in mind. First, Americans
value straightforward dialogue, while the Chinese are masters of the oblique.
Second, at least one member of the US team should have full knowledge of every
aspect of the business. Third, the Chinese may appear indifferent to the success
or failure of the meeting during the negotiations, and then make excessive demands.
In this situation, it is best for the foreign company to remain calm and consider
giving the Chinese company some leeway over a specific issue – it may
result in far greater benefits in the future. Finally, every detail of the business
partnership should be covered verbally at least twice before the contract is
signed. The contract should be written in English and Chinese to make sure all
points are clear.
CONCLUSION
The medical
device market in China presents a huge opportunity for foreign companies whether
they are outsourcing, establishing a new business entity, or selling their medical
product in China. As China opens its doors wider and makes greater efforts to
increase its presence in the global medical device market, the benefits for
foreign companies in China will continue to grow. However, extensive research,
careful planning and a firm commitment are necessary to be successful in the
China medical device market.
Read
more >> Publications Index
Go to Home
|